Who owns Adverum Biotechnologies, Inc.?
- Ticker: ADVM
- CUSIP Number: 00773u207
Tip: Access positions for across all investors
Analyze quarterly positions in Adverum Biotechnologies with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adverum Biotechnologies stock
Who bought or sold Adverum Biotechnologies, Inc. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Millennium Management | 324k | $1.5M | -5% | Sep 2025 |
|
| Two Sigma Investments | 89k | $402k | 373% | Sep 2025 |
|
| Citadel Advisors | 41k | $187k | -47% | Sep 2025 |
|
| Two Sigma Advisers | 38k | $173k | 256% | Sep 2025 |
|
| D. E. Shaw & Co | 17k | $78k | -36% | Sep 2025 |
|
| Royal Bank of Canada | 14k | $50k | 386% | Sep 2025 |
|
| FMR | 1.9k | $8.8k | -17% | Sep 2025 |
|
| Jones Financial Companies, L.L | 1.0k | $4.5k | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 182.00 | $824.005000 | 100% | Sep 2025 |
|
Who sold out of Adverum Biotechnologies?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BML Capital Management | Sep 2025 | 3.1M | $14M |
| Principia Wealth Advisory | Sep 2025 | 2.1M | $9.4M |
| Frazier Life Sciences Management | Sep 2025 | 2.1M | $9.4M |
| TCG Crossover Management | Sep 2025 | 1.7M | $7.6M |
| Vanguard Group | Sep 2025 | 872k | $4.0M |
| 5AM Venture Management | Sep 2025 | 542k | $2.5M |
| Goldman Sachs Group | Sep 2025 | 403k | $1.8M |
| Renaissance Technologies | Sep 2025 | 364k | $1.6M |
| Pale Fire Capital SE | Sep 2025 | 363k | $1.6M |
| BlackRock | Sep 2025 | 311k | $1.4M |
| Soleus Capital Management | Sep 2025 | 287k | $1.3M |
| Dimensional Fund Advisors | Sep 2025 | 235k | $1.1M |
| Geode Capital Management | Sep 2025 | 185k | $837k |
| Regeneron Pharmaceuticals | Sep 2025 | 181k | $820k |
| Warren Averett Asset Management | Sep 2025 | 161k | $729k |
| State Street Corporation | Sep 2025 | 69k | $311k |
| Susquehanna International | Sep 2025 | 58k | $260k |
| Quinn Opportunity Partners | Sep 2025 | 41k | $188k |
| Marshall Wace | Sep 2025 | 28k | $129k |
| Northern Trust | Sep 2025 | 28k | $127k |
| Qube Research & Technologies | Sep 2025 | 22k | $98k |
| Point72 Asia | Jun 2025 | 15k | $31k |
| JustInvest | Sep 2025 | 13k | $58k |
| XTX Topco | Sep 2025 | 13k | $57k |
| Squarepoint Ops | Sep 2025 | 11k | $51k |
| Captrust Financial Advisors | Jun 2025 | 10k | $22k |
| UBS Group | Sep 2025 | 5.6k | $25k |
| Cubist Systematic Strategies | Jun 2025 | 1.9k | $4.1k |
| Advisor Group Holdings | Sep 2025 | 1.7k | $7.7k |
| Bnp Paribas Arbitrage, Snc | Sep 2025 | 540.00 | $2.4k |
| Point72 | Jun 2025 | 225.00 | $483.997500 |
| UMA Financial Services | Sep 2025 | 217.00 | $984.008200 |
| Hanson McClain Advisors | Sep 2025 | 102.00 | $462.998400 |
| SBI Securities | Sep 2025 | 84.00 | $380.998800 |